Court Rules in Favor of Volcano in OCT Case
October 7, 2010 – The Superior Court of Massachusetts has ruled against LightLab Imaging in the company’s optical coherence tomography (OCT) trade secret case against Volcano and its wholly owned subsidiary, Axsun Technologies. LightLab Imaging is a wholly owned subsidiary of St. Jude Medical.
LightLab was purchased in May by St. Jude after the company gained U.S. Food and Drug Administration (FDA) clearance for its OCT intravascular imaging system. It is the first OCT system cleared for use in the United States. Both LightLab and Volcano have OCT systems cleared for commercial use in Europe and Volcano plans to seek FDA clearance for its system.
In a 16-page decision, the court rejected LightLab's claims for protection of five alleged trade secrets relating to laser technologies. It also denied all of LightLab's requests for permanent injunctions. The ruling followed a two-week trial on five of a number of trade secret claims alleged by LightLab. A trial on the remaining trade secret claims has not yet been scheduled.
For more information: www.volcanocorp.com